IM Cannabis

IM Cannabis is an international cannabis company focused on providing premium cannabis products to medical patients in Israel and Germany.

Health Tech & Life Sciences
Active
Public Glil Yam, Israel Founded 2008
Last updated 2026-11-06
Total raised
$87.6M
Last: Convertible Debt 2026-11
Stage
Public
Founded
2008
Headcount
44
HQ
Glil Yam, Israel
Sector
Health Tech & Life Sciences

About

IM Cannabis Corp. is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany. The company operates through an integrated model that includes import, distribution, retail pharmacies, and digital platforms. It leverages a data-driven approach and a globally sourced product supply chain. The company's ecosystem in Israel operates through subsidiaries that import and distribute cannabis, and it also runs medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs. In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients. The company is singularly focused on reaching sustainable profitability through active cost management and margin improvement while maintaining sales.

Funding history · 17 rounds · $87.6M total

17 events/rounds · $87.6M Total Funding: $22.4M in Private Equity, $57.1M in Public Equity, $8.0M in Debt
Sep 2026
Convertible Debt Undisclosed prnewswire.com ↗
Sep 2026
Follow-on PO $1.3M prnewswire.com ↗
★ Creditors★ Selling shareholders★ L.I.A. Pure Capital Ltd.★ Invest-Pro Shukai Hon Ltd.★ certain accredited investors★ Invest-Pro★ accredited investors★ certain holders of the Company (Holders)Eli ZamirINVEST-PROother purchasersAccredited investorsCertain holders of the Company
Apr 2026
Convertible Debt $550K stocktitan.net ↗
Jan 2026
Debt Financing $2.2M imcannabis.com ↗
★ Accredited investors★ Arm's length third party★ Invest-Pro (linked to director Eli Zamir)★ L.I.A. Pure Capital Ltd.★ Certain accredited investors★ Invest-Pro - Shukai Hon Ltd.Pure CapitalLender (unnamed)Invest-Pro Shukai Hon Ltd.certain accredited investors
Jan 2026
Debt Financing $1.5M imcannabis.com
Jan 2026
Debt Financing $633K imcannabis.com
Nov 2024
Seed Undisclosed fundzwatch.ai ↗
★ Management-led★ A.D.I. Car Alarms & Stereo Systems
May 2024
Debt Financing $2.2M imcannabis.com
★ Creditors★ Oren Shuster★ Shmulik Arbel★ Lender (arm's length third party)Not specifiedArm's length third party (Lender)
Sep 2023
Debt Financing $950K prior (startupim db)
Dec 2022
PIPE $6.7M prior (startupim db)
Dec 2022
PIPE $2.0M prior (startupim db)
Sep 2022
PIPE $3.0M gowlingwlg.com
Jul 2022
PIPE $5.0M prior (startupim db)
Jul 2020
Pre-Seed Undisclosed fundzwatch.ai ↗
Oct 2019
Reverse Merger $22.4M sec.gov

Acquisitions · 8

Sep 2026
Space Defense Innovations LLC Undisclosed
Mar 2026
Blackaxe Technologies Undisclosed
Mar 2022
Revoly Trading and Marketing Ltd. (dba Vironna) Undisclosed
Mar 2022
R.A. Yarok Pharm Ltd. Undisclosed
Mar 2022
Rosen High Way Ltd. Undisclosed
Mar 2022
Oranim Pharm Undisclosed
Apr 2021
MYM Nutraceuticals Undisclosed
Mar 2021
Trichome Financial Undisclosed

Offices

Glil Yam, Israel · HQ / main office

Q&A

What is IM Cannabis's primary focus?
IM Cannabis is an international cannabis company focused on providing premium cannabis products to medical patients in Israel and Germany.
How many employees does IM Cannabis have?
IM Cannabis has 44 employees, falling within the 11-50 employee bucket.
When was IM Cannabis founded?
IM Cannabis was founded in 2008.
What was IM Cannabis's most recent funding round?
IM Cannabis's most recent funding round was a Convertible Debt round in November 2026, raising $1,200,000.
Which companies has IM Cannabis acquired recently?
IM Cannabis acquired Space Defense Innovations LLC in September 2026 and Blackaxe Technologies in March 2026.
What was the amount raised in IM Cannabis's Public Offering in July 2025?
In July 2025, IM Cannabis raised $4,100,000 in a Public Offering, with lead investors including Lender. Pure Capital Ltd.
What was the amount raised in IM Cannabis's Debt Financing round in January 2026?
In January 2026, IM Cannabis raised $2,171,660 in a. Pure Capital Ltd., Invest-Pro - Shukai Hon Ltd., and Invest-Pro (linked to director Eli Zamir).
What was the amount raised in IM Cannabis's Follow-on Public Offering in September 2026?
In September 2026, IM Cannabis raised $1,310,000 in a. Pure Capital Ltd., Invest-Pro Shukai Hon Ltd., and certain holders of the Company (Holders).

Team · 12

Oren Shuster
Founder · Chief Executive Officer
Uri Birenberg
Founder · founders
Asi Levi
Chief Financial Officer
Richard Balla
CEO and Director, German Operations – Adjupharm GmbH
Yael Harrosh
Chief Legal & Operations Officer
Eyal Fisher
Chief Executive Officer of the IMC Holdings
Anna Taranko
Director Investor and Public Relations
Oz Adler
Chairman of the Board
Moti Marcus
Director
Asaf Yitzhaik
Director
Eli Zamir
Director
Alon Dayan
Director

Sectors & technology

Primary sector
Health Tech & Life Sciences
Target customers

Tags

medical-cannabiscannabispharmaceuticalsbiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteimcannabis.com/
LinkedInlinkedin.com/company/imc-israel

Identifiers & details

Legal nameIM Cannabis Corp.
Founded2008
Employees (exact)44

Acquisitions & public offerings

AcquiredDateAmount
Space Defense Innovations LLC2026-09
Blackaxe Technologies2026-03
Revoly Trading and Marketing Ltd. (dba Vironna)2022-03
R.A. Yarok Pharm Ltd.2022-03
Rosen High Way Ltd.2022-03
Oranim Pharm2022-03
MYM Nutraceuticals2021-04
Trichome Financial2021-03

Radar intelligence

Web history (Wayback)

Domainimcannabis.com

Certificate / subdomain footprint

Subdomains8